期刊： EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2021; 28 (4)
Objective Dabrafenib, an inhibitor of mutated BRAF, has significant clinical activity in melanoma patients but is linked to a spectrum of cutaneous to......
期刊： EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2021; 28 (4)
Haematologic side effects associated with piperacillin/tazobactam (PTZ) treatment are rare but can be fatal. The exact mechanism by which PTZ causes h......
期刊： EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2021; 28 (3)
Objectives The rate of dermal toxicity has been shown to increase in patients receiving pegylated liposomal doxorubicin (PLD), particularly palmar-pla......
期刊： EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2021; 28 (3)
The fixed-dose combination elvitegravir, cobicistat, emtricitabine and tenofovir alafenamide (E/C/F/TAF) is a first-line agent for the treatment of hu......
期刊： EUROPEAN JOURNAL OF HOSPITAL PHARMACY-SCIENCE AND PRACTICE, 2020; 27 (E1)
Objectives To analyse the results of fluorouracil (5-FU) plasma concentration monitoring in patients with advanced colorectal cancer after 5-FU treatm......
期刊： EUROPEAN JOURNAL OF HOSPITAL PHARMACY-SCIENCE AND PRACTICE, 2020; 27 (E1)
Background A combination of methylprednisolone sodium succinate and tropisetron hydrochloride is commonly used to treat the nausea and vomiting associ......
期刊： EUROPEAN JOURNAL OF HOSPITAL PHARMACY-SCIENCE AND PRACTICE, 2020; 27 (E1)
Objective Usage of tacrolimus is complicated by its narrow therapeutic index and wide between- and within-subject pharmacokinetic variability. We aime......
期刊： EUROPEAN JOURNAL OF HOSPITAL PHARMACY-SCIENCE AND PRACTICE, 2019; 26 (3)
Objectives To investigate the consumption trend and prescription pattern of opioids in China from 2006 to 2015, and compare the results with those of ......
期刊： EUROPEAN JOURNAL OF HOSPITAL PHARMACY-SCIENCE AND PRACTICE, 2019; 26 (5)
Background/objectives Little is known about the role of allopurinol use on the risk of hepatocellular carcinoma (HCC). The study aimed to examine the ......
期刊： EUROPEAN JOURNAL OF HOSPITAL PHARMACY-SCIENCE AND PRACTICE, 2019; 26 (5)
Background Is it possible that the mortality rate from acute myocardial infarction (AMI) may decline after interventions by pharmacists? Objective To ......
